Skip to main content
SLSN logo

SLSN · Solesence, Inc.

Track SLSN — free
$0.90 +0.01 (+0.82%) At close · Oct 20
Market Cap
$63.07M
Shares
70.65M
Volume · Oct 20 18.8K Avg daily vol (3M) 28.39K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.90 Open$0.87 Day$0.85–0.93 52W close$0.64–3.88 Avg vol 30d30K Short int382K · 0.5% float · 25.1d Short vol47% Last earningsAug 19, 2026 DataJan 2020–Oct 2026 Filing10-Q · Aug 19

Up next

Next earnings call
Oct 25, 2026 Est · unconfirmed · in 1 wks
filed Aug 19, 2026
call held Aug 19, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$55.37M
Trailing 12 months
Net income (TTM)
−$2.91M
Trailing 12 months
Revenue growth YoY
-24.7%
Year over year
Operating margin
-3.1%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-2.7%
Year over year · fewer shares
Price change (1Y)
-76.6%
Trailing year
Short interest
0.5%
Latest settlement · 25.1 days to cover
View all 122 metrics

AI Brief

Q2 FY26 earnings call · Aug 11, 2026
Q2 FY26

TL;DR. Solésence reported Q2 2026 revenue of $15.3 million (down from $20.4 million) and a net loss of $158,000, while disclosing a historical inventory costing restatement and guiding to a record second half of approximately $35 million and full-year revenue growth versus 2025, supported by $64.9 million in shipped and on-hand orders.

Bullish
  • + Guides to record second-half revenue of approximately $35 million, the strongest in company history
  • + Guides to full-year 2026 revenue growth versus 2025 with shipped and on-hand orders of $64.9 million, up from $60.0 million
  • + Q2 2026 gross margin of 31% achieved on 25% lower revenue, cited as evidence of labor efficiency gains
Bearish
  • − Q2 2026 revenue declined to $15.3 million from $20.4 million year-over-year
  • − Company disclosed a historical inventory costing restatement requiring remediation of internal controls
  • − Swung to a net loss of $158,000 in Q2 2026 from net income of $3.2 million in Q2 2025
  • − Adjusted EBITDA fell to $523,000 from $3.7 million year-over-year, with one-time Refy-related charges of approximately $938,000 cited

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Neutral Momentum Weak Sentiment Bearish Fundamentals Weak Quant / Vol Very High
Market backdrop VIX 17.3 · elevated Equity put/call 0.56
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg −18%
below
Price vs 50-day avg +1%
above
RSI (14) 52
neutral
MACD trend Positive
52-week position 8%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Weak
1-month return +12%
trailing
6-month return −31%
trailing
YTD return −44%
this year
Relative strength −39%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow Distributing
7 of 44 funds reported for Sep 30 · net -975 sh shares
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.54% of float · ▲ +3.2% MoM · 25.1 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
44 holders — mid 6-yr range
Squeeze score 57
elevated · 0–100
Fundamentals
Weak
Revenue growth +19%
Y/Y
Gross margin 26%
contracting
EPS growth −71%
Y/Y
Free cash flow $-13.1M
Quant / Vol
risk profile
Very High
Volatility 106%
annualized · 1-yr
Max drawdown −84%
past year
ATR 10.7%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 1 of last 2
Latest guidance · from the 8-K filed Aug 20, 2026
Revenue · second half of 2026 Maintained $35M
Aug 19, 2026 $35M changed to Aug 20, 2026 $35M
prior FY $62.06M midpoint −43.6% Y/Y
Guided vs delivered · last 2 settled
Revenue 2022
guided at least $40M
$37.32M Miss −6.7%
Revenue first quarter 2022
guided at least $7M
$8.16M In line

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Neutral
2 · 3 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−18% Bearish
Price vs 50-day avg
+1% Bullish
RSI (14)
52 Neutral
MACD trend
Positive Bullish
52-week position
8% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow Distributing
7 of 44 funds reported for Sep 30 · net -975 sh shares
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.54% of float · ▲ +3.2% MoM · 25.1 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
44 holders — mid 6-yr range
Price context
position in its 52-week range
Range low $1 Now $1 · 8% Range high $4
vs 200-day avg -18% vs 50-day avg +1%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted EBITDA non-GAAP $222K Six months ended June 30, 2026 —
shipped and on-hand orders 64.9M as of August 17, 2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Household & Personal Products — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
SLSN
Solesence, Inc.
this stock
$63.07M -43.8% +18.6% — 0.5%
PG
PROCTER & GAMBLE Co
$366.54B +11.2% +3.3% 23.8 1.1%
UL
Unilever PLC
$141.53B -0.3% — — 0.2%
CL
Colgate Palmolive Co
$75.36B +19.6% +1.7% 37.4 3.0%
RBGLY
Reckitt Benckiser Group PLC
$46.35B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
40
% held
4.5%
Reported
7 of 44
Top holder
VANGUARD CAPITAL MANAGEME…
Held Float
View
Held by Funds
Fund positions
33
View
Short & Settlement
Short Interest Rising
Shares short
381.7K
Days to cover
25.1d
Change
+11.9K sh
View
Short Volume
Short vol %
47%
As of
Oct 20, 2026
Short Total
View
Fails to Deliver
FTD shares
5.1K
Value
$4.1K
As of
Sep 23, 2026
View
Off-Exchange
Off-exchange %
49.9%
Week of
Sep 14, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$62.1M
Net income (FY)
$1.8M
EPS diluted
$0.02
View
Filings
SEC Filings
Latest
8-K
Filed
Oct 5, 2026
This year
14
View
Earnings & Events
Webcasts
Last webcast
Aug 19, 2026
View

Performance

5D 20D 120D MTD YTD
SLSN -9.1% +11.7% -30.8% +9.8% -43.8%
SPY -1.2% -0.6% +8.1% +0.8% +12.8%
vs SPY -7.9% +12.2% -38.9% +8.9% -56.5%
Key facts CIK 883107 CUSIP 630079101 13F (30d) 4 filings 4 filers Visit website Investor relations